Molecular Docking Study of Flavonoid Compounds in The Guava Leaves (Psidium Guajava L.) Which Has Potential as Anti-Inflammatory COX-2 Inhibitors by Ahsana, Dina et al.
 LUMBUNG FARMASI ; Jurnal Ilmu Kefarmasian ,Vol 2 No 2, Juli 2021 
P-ISSN : 2715-5943 
E-ISSN : 2715-5277  
67 
Molecular Docking Study of Flavonoid Compounds in The Guava 
Leaves (Psidium Guajava L.) Which Has Potential as Anti-
Inflammatory COX-2 Inhibitors 
 
Dina Ahsana a,1, Andika a,2*, Siti Nashihah a,3 
















Inflamasi yang bersifat progresif cenderung akan merusak dan menimbulkan 
beberapa permasalahan dalam tubuh. Enzim COX-2 merupakan salah satu 
mediator yang berkontribusi besar dalam terjadinya inflamasi progresif. 
Penelitian secara eksperimental daun jambu biji (Psidium guajava L.) terbukti 
memiliki aktivitas anti-inflamasi diduga karena banyak terkandung senyawa 
flavonoid, namun masih belum ada penelitian aktivitasnya terhadap 
penghambatan COX-2 selektif. Tujuan dari penelitian ini yaitu untuk 
mengetahui potensi senyawa flavonoid memiliki aktivitas anti-inflamasi 
penghambat COX-2 selektif menggunakan uji penambatan molekul. Metode: 
31 senyawa flavonoid daun jambu biji didapat dari studi literatur beberapa 
penelitian in-vitro dan kode protein ID: 6COX yang digunakan pada penelitian 
penambatan molekular ini dilakukan energi minimisasi terlebih dahulu. 
Selanjutnya digunakan software docking Autodock4 dengan metode semi-
flexible dan Lamarckian Genetic Algorithm (LGA). Semua senyawa flavonoid 
juga dilakukan prediksi Absorpsi, Distribusi, Metabolisme, Ekskresi, Toksisitas 
(ADMET). Hasil: secara keseluruhan diperoleh semua 31 senyawa uji flavonoid 
daun jambu biji berpotensi sebagai inhibitor COX-2 dan beberapa senyawa uji 
diantaranya memiliki nilai docking ∆G terbaik yang berasal dari Epicatechin-3-
O-Gallate sebesar -9,31 kcal/mol, disusul oleh Gallocatechin sebesar -8,97 
kcal/mol serta Tamarixetin -8,83 kcal/mol. Residu asam amino SER 353, 
TYR 385, SER 530, GLN 192 dan ARG 120 juga banyak berkontibusi dalam 
terbentuknya ikatan hidrogen. Kesimpulan: Epicatechin-3-O-Gallate 
merupakan senyawa uji yang memiliki potensi besar sebagai anti-inflamasi 
inhibitor COX-2 selektif karena memiliki kekuatan dan kestabilan ikatan yang 
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Progressive inflammation tends to damage and cause several problems in the 
body. The COX-2 enzyme is one of the mediators that have a significant 
contribution to progressive inflammation. Experimental study, guava leaves 
(Psidium guajava L.), have anti-inflammatory activity, presumably because they 
contain many flavonoid compounds. However, the lack of those research on 
their action against selective COX-2 inhibition. The purpose of this study is to 
determine the potential for flavonoid compounds to have anti-inflammatory 
activity of selective COX-2 inhibitors using molecular docking. Method: 31 
flavonoids compound of guava leaves found on some literature studies of a 
systematic literature review and protein code ID: 6COX used on this molecular 
docking study by applying minimization energy at first. Next, using Autodock4 
docking software with semi-flexible and Lamarckian Genetic Algorithm (LGA) 
methods. All flavonoid compounds also used screening Absorption, 
Distribution, Metabolism, Excretion, Toxicity (ADMET) prediction. Results: 
Overall results obtained that all 31 compounds of guava leaf flavonoids can 
potentially be COX-2 inhibitors. One of them has the best docking value with 
∆G from Epicatechin-3-O-Gallate of -9.31 kcal/mol is high than the 
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Gallocatechin of -8.97 kcal/mol and -8.83 kcal/mol Tamarixetin. The amino 
acid residues SER 353, TYR 385, SER 530, GLN 192, and ARG 120 
contributed significantly to form hydrogen bonds. Conclusions: Epicatechin-3-
O-Gallate has significant potential as an anti-inflammatory selective COX-2 
inhibitor because it has high bond strength and stability with the lowest energy 
binding when attached to the target protein.  
 
This is an open access article under the CC–BY-SA license. 
Introduction 
Inflammation is a biological body response, 
usually a protective physiological response to tissue 
injury caused by physical trauma, damaging chemical 
agents, and infection with microbiological agents 
(Chen et al., 2018). However, in progressive 
pathological conditions, where antigens dominate the 
situation, the inflammation can damage cells, tissues, 
or organs (Nurtamin, Sudayasa, and Tien 2018). 
The incidence of inflammation is dominated by their 
mediators of pro-inflammatory prostaglandin-
induced cyclooxygenase enzyme, and other research 
shows the inhibition of Cyclooxygenase-2 (COX-2) 
can reduce 75% of the production prostaglandins. In 
contrast, Cyclooxygenase-1 (COX-1) inhibition 
only decreases in 25 % of total prostaglandins in rats 
(Ricciotti and Fitzgerald 2011). From these data, it 
can be seen that the enzyme COX-2 mainly releases 
the prostaglandins that cause inflammation 
compared to COX-1. Additionally, the high 
expression of COX-2 has played a major role in the 
development of serious diseases such as cancer 
(Desai, Prickril, and Rasooly 2018), Alzheimer 
(Guan and Wang 2019), diabetes (Fujita et al. 
2007), osteoarthritis, and rheumatoid arthritis 
(Curtis et al. 2019). On the other side, the 
inflammatory medication that specifically inhibits 
COX-2 is limited, and celecoxib is the drug most 
frequently used. Therefore it is necessary to make 
new drug discovery as a drug candidate.  
Guava leaves (Psidium guajava L.) are known to 
have anti-inflammatory activity. Research from Choi 
et al. (2008) showed that ethanol extract from guava 
leaves fermentation showed an inhibitory effect of 
inducible nitric oxide synthase (iNOS), COX-2, and 
NF kβ activation has induced by lipopolysaccharide 
on RAW 264,7 cells. Researchers assume that guava 
leaves contain lots of flavonoids that might give these 
anti-inflammatory effects. The anti-inflammatory 
activity of these flavonoids was also supported by in 
silico studies on the flavonoid binding model with 
COX-2 exploring that several flavonols and flavones 
containing 2,3-double bonds may act as preferential 
inhibitors COX-2 (D'mello et al. 2011). Recent 
research conducted by Sen et al. (2015) shows that 
the flavonoid fraction of guava leaf extract is effective 
in inhibiting Lipopolysaccharide (LPS) induced 
production of Nitric Oxide (NO) and Prostaglandin 
E2 (PGE2). Other results using either RT-PCR or 
western blot also showed inducible iNOS and COX-
2 inhibiting activity. However, the researchers' Sen et 
al. (2015) weakness is that there is no screening of 
guava leaves' flavonoid contents, so further research 
is needed. 
The method used to identify potential anti-
inflammatory activity in plant compounds, especially 
guava leaves, is molecular docking. Molecular 
docking is a molecular modeling technique used to 
predict how proteins (enzymes) interact with small 
molecules (ligands) (Roy, Kar, and Das 2015). 
Molecular docking in drug development is included 
in the Structure-Based Drug Design (SBDD) group 
by utilizing information from the target protein 
structure to find the protein's active site that binds to 
the drug compound. The prediction of the best active 
site is expected to create a bond between the 
compound and the target protein to form expected 
biological activity (Pranowo 2009; Roy et al. 2015). 
 
Method 
Equipment and Materials 
The hardware used in this molecular docking 
study was the Acer Aspire A514-53G VGA laptop 
with a specification of CoreTM i5-1035G1 
Processor Intel®, 8 Gb RAM, 1 TB Hard disk, SSD 
512 Gb, and Microsoft Windows 10 as an operating 
system. The docking software we are used was 
Autodock 4.2.6, energy minimization of ligand-
protein using Avogadro and Swiss PDB Viewer 
software. Discovery Studio Visualizer and PyMOL 
for visualizing protein-ligand interactions. pkCSM 
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Protein-Ligand Preparation 
Protein target complexed with selective inhibitor 
COX-2 was downloaded in RCSB PDB web in code 
ID: 6COX. All water molecule and non-standard 
residues were removed from the protein structure, 
adding all hydrogen (Yusuf et al. 2018) and 
separating chain A protein with ligand native's SC-
558 using Autodock software (Sohilait, Harno Dwi 
Pranowo, and Winarto Haryadi 2017). Then we 
downloaded the PubChem website for celecoxib, and 
31 flavonoid compounds of guava leaves are from 
Anand et al., 2016; Barbalho et al., 2012; 
Habtemariam, 2019; Jiang et al. 2020; Thome, 
Sudiana, and Bakar 2019 article scientific is as 
ligands. Those five-article scientific had been proven 
by an experimental study in a systematic literature 
review. In this study, all ligands (31 flavonoid 
compounds, celecoxib, and ligand native SC-558) 
were optimized by energy minimization using 
Avogadro software with MMFF94 force field 
parameters (Hussein and Elkhair 2021). Swiss PDB 
Viewer software with GROMOS96 force field for 
protein minimization (Satyanarayana et al. 2018).  
 
Protein-Ligand Docking 
Molecular docking was performed using the 
Autodock Tools (Autodock4 & Autogrid4) 
programs. Kollman and Gastaiger charges were added 
automatically on protein and ligand after identifying 
ligand torsions (Yusuf et al., 2018). Docking 
validation steps start from setting grid box active site 
of protein, grid box dimension size was 40 × 40 × 
40 and coordinate's (X = 22.903 points, Y = 
23.481 points, Z = 46.936 points) with a space of 
0.375 Å. Flexible ligand and rigid macromolecule 
were setting for protein target because this method 
used semi-flexible docking. We did 100 search 
conformation per compound on Autodock 4.2.6 
used the Lamarckian Genetic Algorithm with 150 
population of Size and 2.500.000 maximum number 
of evals (Fuhrmann et al. 2010). The best 
confirmation as a re-docking ligand was comparing 
for validation. Methods docking validation were 
valid if the Root Mean Square Deviation (RMSD) 
score of re-docking and co-crystal ligand was lower 
than 2 Å (Wati, Widodo, and Herowati 2020). The 
visualization analysis of protein-ligand 2-
Dimensional interaction was view by BIOVIA 
Discovery Studio Visualizer and 3-Dimensional 
using PyMol software (Harisna et al. 2021). 
 
ADMET Prediction 
The Absorption, Distribution, Metabolism, 
Excretion, and Toxicity (ADMET) prediction are 
the crucial technique employed in silico 
pharmacokinetic parameters profile of chemical 
compounds that may affect their pharmacodynamic 
activities (Nisha et al. 2016). There is a lot of online 
tools and offline software to predict ADMET. In 
this study, we have used Predicting Small-Molecule 
Pharmacokinetic Properties Using Graph-Based 
Signatures (pcKSM) online web tools to predict 
ADMET quickly and have a highly accurate result 
(D. E. V. Pires, Blundell, and Ascher 2015). Each 
compound model will be predicted on ADMET 
properties tested on hundreds or thousands of drugs 
before getting accurate prediction data. This 
prediction starts by preparing every of the best 
conformation of 33 ligands screened for ADMET 
by changing the format to SMILES and then 
uploading it in pcKSM online web tools. 
 
Results and Discussion 
Molecular docking is an in silico technique that 
can predict the interaction between small ligands 
(compounds) and target proteins in a stable binding 
area. This interaction will show how strong affinity 
(the ability of a compound to bind to a protein 
pocket) is indicated by the binding energy 
(Iheagwam et al., 2019). The success assessment of 
the molecular docking results was analyzed based on 
the RMSD docking validation, the Gibbs Binding 
Energy (∆G), and the Inhibition Constant (IC). 
 
Docking Validation 
Docking validation was carried out to check the 
efficiency of the docking method by comparing co-
crystal ligands and ligand re-docking. This method 
procedure was verified effectively using the RMSD 
parameter with a docking validation value ≤ 2 Å 
(Kartasasmita, Anugrah, and Tjahjono 2015). Based 
on this research, the RMSD value of the validation 
parameter is 1.064 Å, indicating that the ligands and 
receptors docked have valid criteria of the docking 
method, so the method can determine the other 
compounds. The RMSD value ≤ 2 Å shows that the 
native ligand SC-558 position of the co-crystal 
ligand and re-docking ligand is not too far away, and 
the conformation is very similar (Adelina 2014). 
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Figure 1 Overlapping visualization SC-558 native 
ligand of co-crystal (green-dark blue) and re-




Gibbs Free Energy (ΔG) and Inhibition Constant 
(IC) 
The best docking results can be analyzed by 
comparing the ΔG and the IC value. Gibbs binding 
energy indicated the strength of a ligand-receptor 
bond (affinity). The lowest Gibbs binding energy 
value (the value is getting negative) indicates the best 
ligand and receptor bond stability level. The bonds 
formed are stronger and have maximum inhibitory 
activity (Abdillah, Ilmah, and Mahardhika 2017). 
The IC plays an essential role in evaluating molecular 
docking because it determines how strong the 
protein-ligand bond produces inhibitory activity 
(Kelutur, Mustarichie, and Umar 2020)
Table 1 Docking result of protein-ligand with Autodock4 
No Chemical compounds Gibbs free energy (∆G) Inhibition Constant (IC) 
1 SC-558 - 10.96 kcal/mol 9.30 nM (nanomolar) 
2 Celecoxib - 10.37 kcal/mol 24.84 nM (nanomolar) 
3 Epicatechin-3-O-Gallate - 9.31 kcal/mol 149.65 nM (nanomolar) 
4 Gallocatechin - 8.97 kcal/mol 266.19 nM (nanomolar) 
5 Tamarixetin - 8.83 kcal/mol 335.71 nM (nanomolar) 
6 Myricetin - 8.65 kcal/mol 458.73 nM (nanomolar) 
7 Leucocyanidin - 8.45 kcal/mol 642.15 nM (nanomolar) 
8 Isorhamnetin - 8.41 kcal/mol 680.34 nM (nanomolar) 
9 Cyanidin - 8.41 kcal/mol 684.37 nM (nanomolar) 
10 Phlorizin - 8.40 kcal/mol 699.50 nM (nanomolar) 
11 Guaijaverin - 8.38 kcal/mol 718.67 nM (nanomolar) 
12 Catechin - 8.35 kcal/mol 753.51 nM (nanomolar) 
13 Quercetin - 8.34 kcal/mol 766.90 nM (nanomolar) 
14 Delphinidin - 8.33 kcal/mol 783.60 nM (nanomolar) 
15 Formononetin - 8.28 kcal/mol 850.36 nM (nanomolar) 
16 Naringenin - 8.26 kcal/mol 880.31 nM (nanomolar) 
17 Epicatechin - 8.24 kcal/mol 907.15 nM (nanomolar) 
18 Apigenin - 8.10 kcal/mol 1.16 uM (micromolar) 
19 Phloretin - 8.02 kcal/mol 1.33 uM (micromolar) 
20 Gossypetin - 8.01 kcal/mol 1.34 uM (micromolar) 
21 Biochanin A - 7.99 kcal/mol 1.40 uM (micromolar) 
22 Genistein - 7.91 kcal/mol 1.60 uM (micromolar) 
23 Morin - 7.88 kcal/mol 1.68 uM (micromolar) 
24 Kaempferol - 7.88 kcal/mol 1.69 uM (micromolar) 
25 Isoformononetin - 7.83 kcal/mol  1.81 uM (micromolar) 
26 Daidzein - 7.83 kcal/mol 1.82 uM (micromolar) 
27 Esculin - 7.81 kcal/mol 1.88 uM (micromolar) 
28 Glycitein - 7.78 kcal/mol 1.98 uM (micromolar) 
29 Prunetin - 7.64 kcal/mol 2.51 uM (micromolar) 
30 Daidzin - 5.14 kcal/mol 172.11 uM (micromolar) 
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31 Sissotrin - 5.05 kcal/mol 198.63 uM (micromolar) 
32 Genistin - 4.85 kcal/mol 279.37 uM (micromolar) 
33 Ononin - 4.35 kcal/mol 651.65 uM (micromolar) 
The molecular docking data on the ID: 6COX 
protein in Table 1 shows the compounds with the 
lowest docking value, namely the Ononin with a ∆G 
value of - 4.35 kcal/mol and IC of 651.65 uM. 
While the results of the best docking of the flavonoid 
compound were occupied by the Epicatechin-3-O-
Gallate compound with ∆G = - 9.31 kcal/mol and 
IC of 149.65 nM (nanomolar), then followed by the 
Gallocatechin compound ∆G = - 8.97 kcal/mol and 
IC = 266.19 nM (nanomolar), with Tamarixetin ∆G 
= - 8.83 kcal/mol and IC = 335.71 nM 
(nanomolar). 
The data of free bond energy (∆G) shows that 
the most stable compound is the Epicatechin-3-O-
Gallate compound, followed by the Gallocatechin 
and Tamarixetin compounds. The stability of the 
compound can be seen from its low binding energy. 
The lower the binding energy and the stronger non-
covalent interactions may affect more spontaneous 
reactions between ligands and proteins (Suhadi, 
Rizarullah, and Feriyani 2019). Epicatechin-3-O-
Gallate can be a candidate for COX-2 inhibitor and 
its strength is much higher when compared to 
Gallocatechin and Tamarixetin. 
As shown in the IC data, the smallest value is 
owned by the Epicatechin-3-O-Gallate compound, 
followed by the Gallocatechin and Tamarixetin 
compounds. The smaller the constant inhibition 
value was, the more stable the ligand-receptor 
complex affects the high ability compound is as 
inhibitor COX-2. Based on this study, the 
Epicatechin-3-O-Gallate compound has the highest 
affinity. It has a greater inhibitory power to bind to 
protein, resulting in the drug's biological activity may 
form of more potent COX-2 inhibition. In other 
words, the Epicatechin-3-O-Gallate compound has a 
more significant potential to inhibit COX-2 
compared to other compounds. The constant 
inhibition value can also be used to reference or 
compare in conducting the in vitro (IC50). 
In this study, the Epicatechin-3-O-Gallate 
compound had the most significant potential in 
inhibiting COX-2. The finding of this research 
follows Al-Sayed and Abdel-Daim's (2018) research, 
which also showed the anti-inflammatory activity of 
the Epicatechin Gallate compound in mice induced 
by carrageenan in vivo and there was inhibition of 
high concentrations of the anti-inflammatory 
mediator PGE2. PGE2 are major pro-inflammatory 
induced by COX-2 than COX-1. 
The Gallocatechin compound is in the second 
position based on the docking score ranking after the 
Gallocatechin compound, which may have anti-
inflammatory COX-2 inhibitor potential. This 
prediction is corroborated by research from Gürbüz 
et al. (2019), which states that the Epicatechin 
Gallate compound has anti-inflammatory activity 
and an inhibitor by reducing iNOS and COX-2 
levels in RAW 264.7 cells induced by LPS + IFN-
γ through RT-PCR screening. 
Tamarixetin is the third compound that has the 
highest docking value after Epicatechin-3-O-Gallate 
and Gallocatechin. The docking value shows that the 
Tamarixetin compound has the potential as a 
selective COX-2 enzyme inhibitor. The prediction 
of Tamarixetin as a COX-2 inhibitor is supported by 
in vitro experimental studies from Park et al. (2018), 
where Tamarixetin compounds have anti-
inflammatory activity by inhibiting the 
phosphorylation of JNK1, p38, and Akt, and 
inhibiting COX-2 expression in Bone Marrow 
Dendritic Cells (BMDCs) stimulated by LPS. 
Based on the research above, it has been shown 
that the three compounds with the highest docking 
value (Epicatechin-3-O-Gallate, Gallocatechin and 
Tamarixetin) not only have the potential to have 
anti-inflammatory activity by in silico docking but 
some of them have been proven experimentally to 
have anti-inflammatory activity particularly specific 
as a COX-2 inhibitor. 
 
Amino Acid Residues Interaction 
Observation of amino acid residues from the 
interaction of the flavonoid compound with the 
target protein aims to identify the interactions that 
occur and are thought to contribute to the emergence 
of pharmacological effects such as COX-2 inhibitors 
by the flavonoid compound. These bond interactions 
are hydrogen bonds, hydrophobic interactions, Van 
der Waals interactions, electrostatic interactions, and 
halogens (Oo et al., 2016). Hydrogen bonds play a 
major role in the inhibition of molecular protein 
complexes. On the other hand, hydrogen bonds also 
make protein-ligand complexes stable and produce 
biological activity (Ya'u Ibrahim et al. 2020). 
Hydrogen bonds are the strongest of the non-
covalent bonds but weaker than ionic or covalent 
bonds. Therefore, the amino acid with the most 
hydrogen bonds is possible to be the most significant 
contributor in producing the best activity.
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Table 2 Amino acid residue interaction formed hydrogen bond 
No Compounds Hydrogen Bond 
1 SC-558 Conventional Hydrogen Bond: ARG 120 (2.25 Å), ARG 120 (2.09 Å), GLN 192 (2.07 Å), 
LEU 352 (2.19 Å). 
Carbon Hydrogen Bond: - 
2 Celecoxib Conventional Hydrogen Bond: ARG 120 (2.12 Å), ARG 120 (2.50 Å), GLN 192 (1.98 Å), 
LEU 352 (2.12 Å), PHE 518 (2.94 Å), TYR 355 (2.76 Å). 
Carbon Hydrogen Bond: - 
3 Epicatechin-3-O-
Gallate 
Conventional Hydrogen Bond: ARG 120 (2.09 Å), ARG 120 (2.85 Å), GLN 192 (2.14 Å), 
PHE 518 (2.55 Å), ARG 513 (2.22 Å).  
Carbon Hydrogen Bond: SER 353 (2.80 Å). 
4 Gallocatechin Conventional Hydrogen Bond: GLN 192 (2.24 Å), PHE 518 (2.77 Å), MET 522 (2.20 Å), 
TYR 385 (2.41 Å), VAL 349 (2.47 Å), SER 353 (1.95 Å), SER 353 (2.60 Å), HIS 90 
(1.99 Å) HIS 90 (2.17 Å). 
Carbon Hydrogen Bond: - 
5 Tamarixetin Conventional Hydrogen Bond: GLN 192 (2.10 Å), PHE 518 (2.24 Å), VAL 349 (2.70 Å), 
SER 530 (2.10 Å), MET 522 (2.14 Å). 
Carbon Hydrogen Bond: SER 353 (2.93 Å). 
 
Actually, there are 17 types of amino acids form 
hydrogen bonds derived from the interaction of 33 
ligands and the ID: 6COX protein, but on Table 2 
above, we show amino acid interaction of 5 ligands 
with the high docking score. The amino acid 
interaction and 3D visualization of 5 ligands already 
showed on Fig.2 ligand native SC-558, Fig.3 
Celecoxib, Fig.4 Epicatechin-3-O-gallate, Fig.5 
Gallocatechin and Fig.6 Tamarixetin. 
In this study, the TYR 385 formed 23 
interaction is the amino acid that most contributes to 
forming hydrogen bonds between ligands and 
protein ID: 6COX. This research supported by 
Yanuar, Setiajid, and Hayun (2014) on docking and 
simulating the molecular dynamics of the 
cyclooxygenase-2 complex with several 
Kuinazolinone derivative compounds form hydrogen 
bonds with a percentage of occupancy above 90% 
(very strong hydrogen bonds) on the TYR 385 
residue. Whereas in Basumatary et al. (2018) 
research related to compound 2, 3-Dimethylmaleic 
Anhydride forms a hydrogen bond interaction with 
TYR 385 on the protein A chain. The two above 
research were carried out on the COX-2 protein with 
the same code, namely the protein ID: 6COX. 
The SER 353 amino acid residue formed 29 
hydrogen bonding interactions in this study. In a 
study by Meenambiga, Rajagopal, and Durga (2015) 
using the ID: 6COX protein, it was stated that one 
of the SER 353 residues was in the active site area of 
the COX-2 enzyme. The same research from Yanuar 
et al. (2014) above found that SER 353 residues also 
had an occupancy percentage above 90% (very 
strong hydrogen bonds). 
This study shows that SER 530 amino acid 
residues were also found to make 18 hydrogen 
bonding interactions. SER 530 residue also formed 
hydrogen bonds in the research of  Basumatary et al. 
(2018) regarding the interaction of Compound 2, 3-
Dimethylmaleic Anhydride with molecular docking 
and molecular dynamics studies using protein ID: 
6COX. 
The amino acid residues of GLN 192 formed 18 
hydrogen bonding interactions in the 15 compounds 
with the highest docking ranking. In another study, 
GLN 192 residues were also shown to form 
hydrogen bonds by docking on the derivative 2,4-
Diaryl-5-4H-imidazolone to design anti-
inflammatory activity with the protein ID: 6COX 
(El-Araby et al. 2012). 
Based on this research, the amino acid residues of 
ARG 120 formed many hydrogen bond interactions 
in the three compounds with the top docking (SC-
558, Celecoxib, and Epicatechin-3-O-Gallate 
compounds). In the research of Alagumuthu, 
Sathiyanarayanan, and Arumugam (2015), ARG 
120 residues played a role in forming inhibitory 
biological activity of COX-2, related to their 
research in the form of COX-2 (ID: 6COX) 
inhibitory activity by Isoquinolin derivative 
compounds. 
In this study amino acid of  SER 353, TYR 385, 
SER 530, GLN 192, and ARG 120 has contributed 
to the formatted hydrogen bonds, those 5 residues 
are also found in other studies. This research shows 
that the ligand in the molecule docking process on 
the target protein is in the right place on the active 
site. This is evidenced by the similarity of the 
hydrogen bonding interactions of the five amino acid 
residues above.  
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Figure 2 Molecular docking visualization of ligand native SC-558: (a) 2D diagram of hydrogen bond and other 




Figure 3 Molecular docking visualization of celecoxib (a) 2D diagram of hydrogen bond and other 




Figure 4 Molecular docking visualization of Epicatechin-3-O-gallate: (a) 2D diagram of hydrogen bond and 
other intermolecular interaction between Epicatechin-3-O-gallate and A chains protein; (b) Epicatechin-3-O-
gallate on binding pocket protein ID: 6COX 
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Figure 5 Molecular docking visualization of Gallocatechin: (a) 2D diagram of hydrogen bond and other 
intermolecular interaction between Gallocatechin and A chains protein; (b) Gallocatechin on binding pocket 
protein ID: 6COX 
 
Figure 6 Molecular docking visualization of Tamarixetin: (a) 2D diagram of hydrogen bond and other 




The discovery of new drugs is not only seen by 
the strength of the ligand binding on the target 
protein. However, it is also evaluated in terms of 
pharmacokinetics and toxicity to determine the 
degree of effectiveness and therapeutic efficacy. 
Pharmacokinetic processes or drug travel in the body 
start from Absorption, Distribution, Metabolism, 
and Excretion (ADME). Predicting Small-Molecule 
Pharmacokinetic Properties Using Graph-Based 
Signatures or pkCSM is a site that provides 
predictions of ADMET properties in new chemical 
compounds with a high degree of accuracy. ADMET 
screened all flavonoid compounds through the 
pkCSM web server, and ADMET predictions were 
displayed from the three best dockings of flavonoid 
compounds include Epicatechin-3-O-gallate, 
Gallocatechin, and Tamarixetin. 
 
 
Table 3 Predicted pcKSM of flavonoid compounds 
Models  unit 
Compounds Parameters (D. E. V 






     
Caco2 permeability Numeric (log 
Papp in 10-6 
cm/s) 





63,139 58,153 72.71 Poorly absorbed if less 
than 30% 
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Skin Permeability Numeric (log Kp) -2,735 -2,735 -2,735 Low skin permeability if 
log Kp > -2.5 
Distribution 
     
VDss (human) Numeric (log 
L/kg) 
0.683 0.999 -0.09 Low VDss if log VDss < 
-0.15 
High VDss if log VDss 
> 0.45 
BBB permeability Numeric (log BB) -1,992 -1.57 -1,294 Good distribution to the 
brain if logBB > 0.3 
Bad distribution to the 
brain if logBB < -1 
CNS permeability Numeric (log PS) -3,734 -3,514 -3,246 Can penetrate the CNS if 
Log PS > -2 
Unable to penetrate the 
CNS if Log PS < -3 
Metabolism 
     
CYP2D6 substrate Categorical 
(Yes/No) 
























No No No 
 
Excretion 
     
Total Clearance Numeric (log 
ml/min/kg) 
-0.213 0.268 0.513 
 
Renal OCT2 substrate Categorical 
(Yes/No) 
No No No 
 
Toxicity 
     
AMES toxicity Categorical 
(Yes/No) 
No No No 
 
hERG I inhibitor 
 
No No No 
 
hERG II inhibitor 
 








No No No 
 
T.Pyriformis toxicity Numeric (log 
ug/L) 
0.285 0.311 0.355 Compound predicted 
toxic if Log > 0.5 ug/L 
Minnow toxicity Numeric (log 
mM) 
5,906 5,068 3,478 Compound predicted 
high acute toxic if Log  
< -0.3 
Epicatechin-3-O-gallate, Gallocatechin, and 
Tamarixetin have slightly low permeability to Caco2 
permeability in the human intestinal mucosa. However, 
it is predicted to have good absorption of Intestinal 
human absorption, which means all compounds can 
absorb through small intestinal humans. On another 
side, those three flavonoid compounds have high skin 
permeability, so it is predicted that the preparations can 
be made in the topical formulation with the 
transdermal route. 
Prediction in the distribution phase, it is possible 
that the three flavonoid compounds Epicatechin-3-O-
gallate, Gallocatechin, and Tamarixetin can be 
distributed more in the network because all compounds 
have high VDss (human) (log> 0.45). However, the 
permeability to BBB & CNS is insufficient (not suitable 
for targeting as drug candidates for BBB & CNS, 
possibly because of their low lipophilicity). 
Based on metabolism prediction, the three 
compounds, such as Epicatechin-3-O-gallate, 
Gallocatechin, and Tamarixetin do not inhibit the drug 
metabolism process carried out by cytochrome P450, 
and inhibit CYP1A2 does not have a major effect on 
the process of drug metabolism. The substrate 
prediction shows that three compounds can be 
appropriately metabolized by cytochrome P450 and are 
easily excreted. 
Tamarixetin produced the highest rate of total 
clearance in the excretion compound prediction 
compared to Epicatechin-3-O-gallate and 
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gallocatechin. These three compounds are also not a 
Renal OCT2 substrate, so it is predicted that they will 
not cause toxicity if they are made for oral drug delivery 
that is taken together with Renal OCT2 inhibitors. 
Epicatechin-3-O-gallate, Gallocatechin, and 
Tamarixetin were predicted not to cause mutations in 
the predicted AMES and were not hepatotoxic. In the 
hERG inhibitor, only the Epicatechin-3-O-gallate 
compound is a possible hERG inhibitor (a side effect 
may create heart problems). The three compounds were 
also predicted to have toxicity to protozoa in the T. 
Pyriformis toxicity but low toxicity to the environment 
in the Minnow Toxicity.  
 
Conclusion and Recommendation 
Research on the flavonoid compounds on the ID: 
6COX protein as a COX-2 inhibitor using the 
molecular docking obtained the best free bond energy 
(∆G) as the results of the flavonoid compound, the 
high-rank value of -9.31 kcal/mol were from the 
Epicatechin-3-O-Gallate, which have potential activity 
as COX-2 inhibitors and amino acid residues most 
playing role of this research is SER 353, TYR 385, 
SER 530, ARG 120, and GLN 192. In future research, 
we expect new prospective studies to demonstrate 
further Molecular Dynamic or QSAR using the best 
docking rank of flavonoids compound to evaluate bond 
strength and biological activity. 
 
References  
Abdillah, Muhammad Nur, Nefi Rofani Ilmah, and 
Andhika Bintang Mahardhika. 2017. 
“Penambatan Molekuler Senyawa Polifenolat 
Terhadap Enzim Reverse Transcriptase 
Sebagai Senyawa Antiretroviral (HIV-1).” 
JSTFI Indonesian Journal of Pharmaceutical 
Science and Technology 6(1):36–44. 
Adelina, Rosa. 2014. "Molecular Docking Studies of 
Annomuricin E and Muricapentocin on 
Antiproliferation Activity." Pp. 32–36 in 
Jurnal Ilmu Kefarmasian Indonesia. Vol. 12. 
Al-Sayed, Eman, and Mohamed M. Abdel-Daim. 
2018. "Analgesic and Anti-Inflammatory 
Activities of Epicatechin Gallate from 
Bauhinia Hookeri." Drug Development 
Research 79(4):157–64. doi: 
https://doi.org/10.1002/ddr.21430. 
Alagumuthu, Manikandan, Kulathu Iyer 
Sathiyanarayanan, and Sivakumar Arumugam. 
2015. "Molecular Docking, Design, 
Synthesis, in Vitro Antioxidant and Anti-
Inflammatory Evaluations of New 
Isoquinoline Derivatives." International 
Journal of Pharmacy and Pharmaceutical 
Sciences 7(12):200–208. 
Anand, Vijaya, Manikandan, Vijaya Kumar, Sampath 
Kumar, Pushpa, and Agaath Hedina. 2016. 
"Phytopharmacological Overview of Psidium 
Guajava Linn." Pharmacognosy Journal 
8(4):314–20. doi: 
https://doi.org/10.5530/pj.2016.4.3. 
Barbalho, Sandra M., Flávia M. V Farinazzi-machado, 
Ricardo De Alvares Goulart, Anna Cláudia, 
Saad Brunnati, and Alda Maria Machado. 
2012. “Psidium Guajava (Guava): A Plant of 
Multipurpose Medicinal Applications.” 
Medicinal & Aromatic Plants 01(04):1–6. 
doi: https://doi.org/10.4172/2167-
0412.1000104. 
Basumatary, Panchamita, Manas Das, Pranjan Barman, 
and Manisha Choudhury. 2018. "Molecular 
Docking Study of 2, 3-Dimethylmaleic 
Anhydride (3, 4-Dimethyl-2, 5-Furandione) 
as Anti-Inflammatory Agent." Trends in 
Bioinformatics 11(2):56–63. doi: 
https://doi.org/10.3923/tb.2018.56.63. 
Chen, Linlin, Huidan Deng, Hengmin Cui, Jing Fang, 
Zhicai Zuo, Junliang Deng, Yinglun Li, Xun 
Wang, and Ling Zhao. 2018. "Inflammatory 
Responses and Inflammation-Associated 




Choi, Soo-Youn, Joon-Ho Hwang, Soo-Young Park, 
Yeong-Jun Jin, Hee-Chul Ko, Sang-Wook 
Moon, and Se-Jae Kim. 2008. "Fermented 
Guava Leaf Extract Inhibits LPS- Induced 
COX-2 and INOS Expression in Mouse 
Macrophage Cells by Inhibition of 
Transcription Factor NF-ΚB." Phytotherapy 
Research 22(4):1030–1034. doi: 
https://doi.org/10.1002/ptr.2419. 
Curtis, Elizabeth, Nicholas Fuggle, Sarah Shaw, Laura 
Spooner, Georgia Ntani, Camille Parsons, 
Nadia Corp, Germain Honvo, Janis Baird, 
Stefania Maggi, Elaine Dennison, Olivier 
Bruyère, Jean Yves Reginster, and Cyrus 
Cooper. 2019. "Safety of Cyclooxygenase-2 
Inhibitors in Osteoarthritis: Outcomes of a 
Systematic Review and Meta-Analysis." 
Drugs and Aging 36(1):25–44. doi: 
https://doi.org/10.1007/s40266-019-
00664-x. 
D'mello, Priscilla, Manoj Kumar Gadhwal, Urmila 
Joshi, and Preetam Shetgiri. 2011. "Modeling 
of COX-2 Inhibitory Activity of Flavonoids." 
International Journal of Pharmacy and 
Pharmaceutical Sciences 3(4):33–40. 
 LUMBUNG FARMASI ; Jurnal Ilmu Kefarmasian ,Vol 2 No 2, Juli 2021 
P-ISSN : 2715-5943 
E-ISSN : 2715-5277  
77 
Desai, Shreena J., Ben Prickril, and Avraham Rasooly. 
2018. "Mechanisms of Phytonutrient 
Modulation of Cyclooxygenase-2 (COX-2) 
and Inflammation Related to Cancer." 
Nutrition and Cancer 70(3):350–75. doi: 
https://doi.org/10.1080/01635581.2018.
1446091. 
El-Araby, Moustafa, Abdelsattar Omar, Hassanein H. 
Hassanein, Abdel Ghany H. El-Helby, and 
Asharf A. Abdel-Rahman. 2012. "Design, 
Synthesis and in Vivo Anti-Inflammatory 
Activities of 2,4-Diaryl-5-4H-Imidazolone 




Fuhrmann, Jan, Alexander Rurainski, Hans-Peter 
Lenhof, and Dirk Neumann. 2010. "A New 
Lamarckian Genetic Algorithm for Flexible 
Ligand-Receptor Docking." Journal of 
Computational Chemistry 31(9):1911–1918. 
doi: https://doi.org/10.1002/jcc.21478. 
Fujita, Hiroki, Masafumi Kakei, Hiromi Fujishima, 
Tsukasa Morii, Yuichiro Yamada, Zhonghua 
Qi, and Matthew D. Breyer. 2007. "Effect of 
Selective Cyclooxygenase-2 (COX-2) 
Inhibitor Treatment on Glucose-Stimulated 
Insulin Secretion in C57BL/6 Mice." 
Biochemical and Biophysical Research 
Communications 363(1):37–43. doi: 
10.1016/j.bbrc.2007.08.090. 
Guan, Pei Pei, and Pu Wang. 2019. "Integrated 
Communications between Cyclooxygenase-2 
and Alzheimer's Disease." The FASEB 
Journal 33(1):1–21. doi: 
https://doi.org/10.1096/fj.201800355RR
RR. 
Gürbüz, Perihan, Şengül Dilem Doğan, Gizem Nur 
Çelik, Hatice Bekci, Ahmet Cumaoğlu, 
Miyase Gözde Gündüz, and Mehmet Yavuz 
Paksoy. 2019. “Bioactivity-Guided Isolation 
of Anti-Inflammatory Principles from Cistus 
Parviflorus Lam.” Records of Natural 
Products 13(3):226–35. doi: 
https://doi.org/10.25135/RNP.106.18.09
.883. 
Habtemariam, Solomon. 2019. The Chemical and 
Pharmacological Basis of Guava (Psidium 
Guajava L.) as Potential Therapy for Type 2 
Diabetes and Associated Diseases. Elsevier 
Ltd. 
Harisna, Azza Hanif, Rizky Nurdiansyah, Putri Hawa 
Syaifie, Dwi Wahyu Nugroho, Kurniawan 
Eko Saputro, Firdayani, Chandra Dwi 
Prakoso, Nurul Taufiqu Rochman, 
Nurwenda Novan Maulana, Alfian 
Noviyanto, and Etik Mardliyati. 2021. "In 
Silico Investigation of Potential Inhibitors to 
Main Protease and Spike Protein of SARS-
CoV-2 in Propolis." Biochemistry and 
Biophysics Reports 26:1–13. doi: 
https://doi.org/10.1016/j.bbrep.2021.100
969. 
Hussein, R. K., and H. M. Elkhair. 2021. "Molecular 
Docking Identification for the Efficacy of 
Some Zinc Complexes with Chloroquine and 
Hydroxychloroquine against Main Protease 
of COVID-19." Journal of Molecular 
Structure 1231:1–9. doi: 
https://doi.org/10.1016/j.molstruc.2021.1
29979. 
Iheagwam, Franklyn Nonso, Olubanke Olujoke 
Ogunlana, Oluseyi Ebenezer Ogunlana, 
Itunuoluwa Isewon, and Jelili Oyelade. 2019. 
"Potential Anti-Cancer Flavonoids Isolated 
from Caesalpinia Bonduc Young Twigs and 
Leaves: Molecular Docking and in Silico 




Jiang, Lirong, Junyu Lu, Yue Qin, Weirong Jiang, and 
Yanping Wang. 2020. "Antitumor Effect of 
Guava Leaves on Lung Cancer: A Network 




Kartasasmita, Rahmana Emran, Rina Anugrah, and 
Daryono Hadi Tjahjono. 2015. “Kajian 
Docking Dan Prediksi Beberapa Aspek 
Farmakokinetika Desain Molekul Turunan 
Kuinin Sebagai Upaya Menemukan Kandidat 
Senyawa Antimalaria Yang Baru.” Kartika 
Jurnal Ilmiah Farmasi 3(1):6–13. doi: 
https://doi.org/10.26874/kjif.v3i1.13. 
Kelutur, Faruk Jayanto, Resmi Mustarichie, and Abdul 
Kakhar Umar. 2020. “Virtual Screening 
Kandungan Senyawa Kipas Laut (Gorgonia 
Mariae) Sebagai Anti-Asma.” ALCHEMY 
Jurnal Penelitian Kimia 16(2):199–210. doi: 
https://doi.org/10.20961/alchemy.16.2.39
96.199-210. 
Meenambiga, Setti Sudharsan, Kalyanaraman 
Rajagopal, and R. Durga. 2015. "In Silico 
Docking Studies on the Components of 
Inonotus Sp., a Medicinal Mushroom against 
Cyclooxygenase-2 Enzyme." Asian Journal of 
Pharmaceutical and Clinical Research 
8(3):142–45. 
 LUMBUNG FARMASI ; Jurnal Ilmu Kefarmasian ,Vol 2 No 2, Juli 2021 
P-ISSN : 2715-5943 
E-ISSN : 2715-5277  
78 
Nisha, Chaluveelaveedu Murleedharan, Ashwini 
Kumar, Prateek Nair, Nityasha Gupta, 
Chitrangda Silakari, Timir Tripathi, and 
Awanish Kumar. 2016. "Molecular Docking 
and In Silico ADMET Study Reveals 
Acylguanidine 7a as a Potential Inhibitor of B-
Secretase." Advances in Bioinformatics 
2016:1–6. doi: 
https://doi.org/10.1155/2016/9258578. 
Nurtamin, Tomy, I. Putu Sudayasa, and Tien. 2018. 
"In Vitro Anti-Inflammatory Activities of 
Ethanolic Extract Elephantopus Scaber 
Leaves." Jurnal Kedokteran Dan Kesehatan 
Indonesia 9(1):46–52. doi: 
https://doi.org/10.20885/JKKI.Vol9.Iss1.
art9. 
Oo, Adrian, Pouya Hassandarvish, Sek Peng Chin, 
Vannajan Sanghiran Lee, Sazaly Abu Bakar, 
and Keivan Zandi. 2016. "In Silico Study on 
Anti-Chikungunya Virus Activity of 
Hesperetin." PeerJ (10):1–23. doi: 
https://doi.org/10.7717/peerj.2602. 
Park, Hee Jo, Seung Jun Lee, Joon Cho, Amal Gharbi, 
Hee Dong Han, Tae Heung Kang, Yangmee 
Kim, Yeongjoon Lee, Won Sun Park, In Duk 
Jung, and Yeong Min Park. 2018. 
"Tamarixetin Exhibits Anti-Inflammatory 
Activity and Prevents Bacterial Sepsis by 
Increasing IL-10 Production." Journal of 
Natural Products 81(6):1435–43. doi: 
https://doi.org/10.1021/acs.jnatprod.8b00
155. 
Pires, Douglas E. V., Tom L. Blundell, and David B. 
Ascher. 2015. "PkCSM: Predicting Small-
Molecule Pharmacokinetic and Toxicity 
Properties Using Graph-Based Signatures." 




Pires, Douglas E. V, Tom L. Blundell, and David B. 
Ascher. 2015. "PkCSM : Predicting Small-
Molecule Pharmacokinetic Properties Using 
Graph-Based Signatures (Theory- How to 
Enterpret PkCSM Result)." PKCSM 5. 
Pranowo, Harno Dwi. 2009. “Peran Kimia Komputasi 
Dalam Desain Molekul Obat.” Pidato 
Pengukuhan JabatanGuru Besar Pada 
FakultasMatematika Dan Ilmu Pengetahuan 
Alam Universitas Gadjah Mada. 
Ricciotti, Emanuela, and Garret A. Fitzgerald. 2011. 
“Prostaglandins and Inflammation.” 
Arteriosclerosis, Thrombosis, and Vascular 
Biology 31(5):986–1000. doi: 
https://doi.org/10.1161/ATVBAHA.110.
207449. 
Roy, Kunal, Supratik Kar, and Rudra Narayan Das. 
2015. Understanding the Basics of QSAR for 
Applications in Pharmaceutical Sciences and 
Risk Assessment. 
Satyanarayana, Sadam D. V., M. S. R. Krishna, Pindi 
Pavan Kumar, and Sirisha Jeereddy. 2018. "In 
Silico Structural Homology Modeling of Nif 
A Protein of Rhizobial Strains in Selective 
Legume Plants." Journal of Genetic 




Sen, Shib Sankar, V. Sukumaran, Sib Sankar Giri, and 
Se Chang Park. 2015. "Flavonoid Fraction of 
Guava Leaf Extract Attenuates 
Lipopolysaccharide-Induced Inflammatory 
Response via Blocking of NF-ΚB Signalling 
Pathway in Labeo Rohita Macrophages." Fish 
and Shellfish Immunology 47(1):85–92. doi: 
https://doi.org/10.1016/j.fsi.2015.08.031. 
Sohilait, Mario Rowan, Harno Dwi Pranowo, and 
Winarto Haryadi. 2017. "Molecular Docking 
Analysis of Curcumin Analogues with COX-
2." Bioinformation 13(11):356–59. doi: 
https://doi.org/10.6026/9732063001335
6 
Suhadi, Andrio, Rizarullah Rizarullah, and Feriyani 
Feriyani. 2019. “Simulasi Docking Senyawa 
Aktif Daun Binahong Sebagai Inhibitor 
Enzyme Aldose Reductase.” Sel Jurnal 
Penelitian Kesehatan 6(2):55–65. doi: 
https://doi.org/10.22435/sel.v6i2.1651. 
Thome, Angela Librianty, I. Ketut Sudiana, and Abu 
Bakar. 2019. "Psidium Guajava Leaves 
Compound As Anti-Inflammation: 
Systematic Review." Jurnal Natural 
19(3):69–71. doi: 
https://doi.org/10.24815/jn.v19i3.13829. 
Wati, Widia, Gunawan Pamudji Widodo, and Rina 
Herowati. 2020. "Prediction of 
Pharmacokinetics Parameter and Molecular 
Docking Study of Antidiabetic Compounds 
from Syzygium Polyanthum and Syzygium 




Ya’u Ibrahim, Zakari, Adamu Uzairu, Gideon 
Shallangwa, and Stephen Abechi. 2020. 
"Molecular Docking Studies, Drug-Likeness 
and in-Silico ADMET Prediction of Some 
Novel β-Amino Alcohol Grafted 1,4,5-
 LUMBUNG FARMASI ; Jurnal Ilmu Kefarmasian ,Vol 2 No 2, Juli 2021 
P-ISSN : 2715-5943 
E-ISSN : 2715-5277  
79 
Trisubstituted 1,2,3-Triazoles Derivatives as 
Elevators of P53 Protein Levels." Scientific 
African 10:1–8. doi: 
https://doi.org/10.1016/j.sciaf.2020.e005
70. 
Yanuar, Arry, Muhammad Aditya Setiajid, and Hayun. 
2014. “Analisis Penambatan Dan Simulasi 
Dinamika Molekular Komplex 
Siklooksigesinenase-2 Dengan Beberapa 
Senyawa Turunan Kuinazolinon.” Jurnal 
Farmasi Indonesia 7(1):50–59. 
Yusuf, Muhammad, Ari Hardianto, Muchtaridi 
Muchtaridi, Rina F. Nuwarda, and Toto 
Subroto. 2018. Introduction of Docking-
Based Virtual Screening Workflow Using 
Desktop Personal Computer. Vols. 1–3. 
Elsevier Ltd. 
 
 
 
 
 
 
 
 
 
 
 
 
 
